Business Description
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Business History
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 0.28
Total Equity: $3.11B
Shares: 169,200,000
Total Debt: $1.49B
Cash: $1.21B
EBITDA: $329.80M
Total Debt: $1.49B
Cash: $1.21B
Revenue: $2.72B
Revenue: $2.72B
Revenue: $2.72B
Total Equity: $3.11B
Tax Rate: 73.5%
Equity: $3.11B
Total Debt: $1.49B
Cash: $1.21B
Current Liabilities: $852.60M
Long-Term Debt: $1.45B
Total Debt: $1.49B
Total Equity: $3.11B
Shares: 169,200,000
Shares: 169,200,000
CapEx: -$45.30M
Shares: 169,200,000
Stock Price: $26.79
Net Income: $47.00M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 7:55pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.5B | $2.7B |
| Cost of Revenue | $1.0B | $1.1B | $1.1B | $1.1B | $1.2B |
| Gross Profit | $1.5B | $1.5B | $1.5B | $1.4B | $1.5B |
| Operating Expenses | $1.2B | $1.2B | $1.4B | $2.4B | $1.3B |
| Operating Income | $306.2M | $319.2M | $31.5M | -$1.0B | $225.7M |
| Net Income | $340.5M | $243.1M | -$100.2M | -$1.1B | $47.0M |
| EBITDA | $496.0M | $497.7M | $463.0M | $279.5M | $329.8M |
| EPS | $1.63 | $1.46 | $-0.60 | $-6.50 | $0.28 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 7:55pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.1B | $606.9M | $940.0M | $1.1B | $1.2B |
| Total Current Assets | $1.8B | $1.4B | $1.7B | $1.8B | $2.0B |
| Total Assets | $6.6B | $6.6B | $6.6B | $5.4B | $5.7B |
| Current Liabilities | $1.2B | $1.2B | $780.8M | $878.7M | $852.6M |
| Long-Term Debt | $883.4M | $870.7M | $1.4B | $1.3B | $1.4B |
| Total Liabilities | $2.5B | $2.4B | $2.4B | $2.4B | $2.6B |
| Total Equity | $4.1B | $4.2B | $4.2B | $2.9B | $3.1B |
| Retained Earnings | $466.9M | $731.4M | $631.2M | -$487.4M | -$440.4M |
Cash Flow (Annual)
Last updated: Jun 21, 2026 7:55pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $361.6M | $182.7M | $275.7M | $336.5M | $275.7M |
| Capital Expenditure | -$54.7M | -$75.7M | -$58.2M | -$33.8M | -$45.3M |
| Free Cash Flow | $306.9M | $107.0M | $217.5M | $302.7M | $230.4M |
| Acquisitions (net) | $310.4M | -$622.3M | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | -$166.6M |
| Net Change in Cash | $184.7M | -$466.7M | $333.1M | $129.1M | $142.6M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 11:18am (21h ago)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$2.9B $2.8B – $2.9B
|
$3.0B $2.9B – $3.0B
|
$3.1B $3.1B – $3.1B
|
$3.2B $3.1B – $3.2B
|
| EBITDA |
$460.3M $457.1M – $463.5M
|
$476.2M $473.0M – $485.8M
|
$493.5M $493.5M – $493.5M
|
$510.5M $505.7M – $517.9M
|
| Net Income |
$242.3M $237.2M – $247.4M
|
$266.0M $260.8M – $271.1M
|
$270.8M $202.9M – $338.8M
|
$322.3M $318.4M – $328.4M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:55pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +2.4% | -0.1% | -2.2% | +8.3% |
| Gross Profit Growth | +1.8% | -2.5% | -4.1% | +7.5% |
| Operating Income Growth | +4.2% | -90.1% | -3,395.9% | +121.7% |
| Net Income Growth | -28.6% | -141.2% | -1,016.4% | +104.2% |
| EBITDA Growth | +0.3% | -7.0% | -39.6% | +18.0% |
Narrative Economics
market-narrative step).